Skip to main navigation Skip to search Skip to main content

Development and validation of an enzyme linked immunosorbent assay for the quantification of carcinoembryonic antigen in mouse plasma

  • SUNY Buffalo
  • University of Michigan, Ann Arbor

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

Carcinoembryonic antigen (CEA) is a tumor associated antigen that is over-expressed in colorectal cancer and several other cancers of the gastrointestinal system. An enzyme linked immunosorbent assay was developed to determine CEA concentrations in mouse plasma. The assay was validated over the standard curve range of 1-20ng/mL. The intra-assay recoveries ranged from 93-104% with associated percent coefficients of variation (CV%) ranging between 2.5-12.8%. The inter-assay recoveries were in the range of 98.4-105% and their CV% values were between 4.77-10.1%. The assay was used to detect the presence of circulating CEA in the LS174T adenocarcinoma xenograft model and to study the pharmacokinetics of recombinant CEA in athymic mice.

Original languageEnglish
Pages (from-to)418-427
Number of pages10
JournalJournal of Immunoassay and Immunochemistry
Volume30
Issue number4
DOIs
StatePublished - Oct 2009

Keywords

  • Athymic mice
  • Carcinoembryonic antigen (CEA)
  • ELISA
  • Plasma
  • Shed antigen
  • Xenograft

Fingerprint

Dive into the research topics of 'Development and validation of an enzyme linked immunosorbent assay for the quantification of carcinoembryonic antigen in mouse plasma'. Together they form a unique fingerprint.

Cite this